These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 299815)

  • 1. Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.
    Lapi L; Cohen SS
    Biochem Pharmacol; 1977 Jan; 26(1):71-6. PubMed ID: 299815
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of brain adenosine deaminase by 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl) adenine.
    Skolnick P; Nimitkitpaisan Y; Stalvey L; Daly JW
    J Neurochem; 1978 Jun; 30(6):1479-82. PubMed ID: 670988
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
    Plunkett W; Cohen SS
    Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
    Suling WJ; Rice LS; Shannon WM
    Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of cytotoxicity and antitumor activity of adenosine analogs by the adenosine deaminase inhibitor adecypenol.
    Tanaka H; Kawakami T; Yang ZB; Komiyama K; Omura S
    J Antibiot (Tokyo); 1989 Nov; 42(11):1722-4. PubMed ID: 2584153
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
    Deibel MR; Coleman MS; Hutton JJ
    Biochem Med; 1981 Jun; 25(3):288-97. PubMed ID: 6973972
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Adamson RH; Zaharevitz DW; Johns DG
    Pharmacology; 1977; 15(1):84-9. PubMed ID: 840892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of adenosine deaminase and the development of antiviral agents.
    Cohen SS
    Ann N Y Acad Sci; 1985; 451():204-14. PubMed ID: 2416257
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.
    Plunkett W
    Ann N Y Acad Sci; 1985; 451():150-9. PubMed ID: 3907452
    [No Abstract]   [Full Text] [Related]  

  • 11. Adenosine deaminase inhibition for immunosuppression.
    Chassin MM; Chirigos MA; Johns DG; Adamson RH
    N Engl J Med; 1977 May; 296(21):1232. PubMed ID: 854065
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenosine deaminase impairment and ribonucleotide reductase in human cells.
    Elford HL; Lin AL
    Ann N Y Acad Sci; 1985; 451():98-112. PubMed ID: 3907454
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the activity of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nonyl)adenine in vivo.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Biochem Pharmacol; 1979; 28(2):201-6. PubMed ID: 426835
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
    Borondy PE; Chang T; Maschewske E; Glazko AJ
    Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.
    Trotta PP; Ahland MP; Brown GF; Balis ME
    Mol Pharmacol; 1978 Jan; 14(1):199-209. PubMed ID: 625284
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemolysis in mice treated with deoxycoformycin, an inhibitor of adenosine deaminase.
    Smith CM; Belch A; Henderson JF
    Biochem Pharmacol; 1980 Apr; 29(8):1209-10. PubMed ID: 6966932
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycin.
    Johns DG; Adamson RH
    Biochem Pharmacol; 1976 Jun; 25(12):1441-4. PubMed ID: 1084747
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine deaminase inhibitors: differential effects on multiple forms of adenosine deaminase.
    Constine J; Glazer RI; Johns DG
    Biochem Biophys Res Commun; 1978 Nov; 85(1):198-202. PubMed ID: 570397
    [No Abstract]   [Full Text] [Related]  

  • 19. Activated T lymphocytes resist the toxic effects of the adenosine deaminase inhibitor, 2-deoxycoformycin.
    Kotb M; Veit BC
    Cell Immunol; 1982 Sep; 72(1):64-76. PubMed ID: 6983389
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
    Wigand R
    J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.